Impairment Science

What Impairment Science does

Impairment Science, Inc. is a Cambridge, Massachusetts-based privately held company (incorporated 2018, founded 2016 by Dr. Michael Milburn, a UMass Boston psychology professor) that develops DRUID, a mobile application and enterprise platform for detecting cognitive and motor impairment. The technology uses neuroscience-based, game-like tasks measuring reaction time, decision-making accuracy, hand-eye coordination, time estimation, balance, and divided attention to produce a 25-75 impairment score. The product line includes the consumer DRUID App (1-minute Rapid test or 3-minute Benchmark test, sold via Apple App Store and Google Play with a 14-day free trial, $1.99/month or $14.99/year subscription), DRUID Enterprise (a cloud-based portal with real-time monitoring, alerts, scheduling, and API integration to EHSQ/OHS platforms), DRUID True (patent-pending ML anti-cheat technology for unsupervised testing), and a full integration with Neopharma Technologies' NEOVAULT digital drug test reporting forming a unified Fit-for-Duty platform. ML is used both for anti-cheat anomaly detection and for distinguishing alcohol-related from cannabis-related impairment, with F1 accuracy above 0.85 disclosed in peer-reviewed research.

The company serves a multi-segment customer base spanning safety-critical industries (mining, construction, manufacturing), emergency services (fire/EMS), the cannabis industry (dispensaries, consumption lounges), academic and research institutions (notably a 10,000-participant Johns Hopkins National Cannabis Study), and individual consumers. Named enterprise and government customers include Impala Canada, Wilmot Modular Structures, Golder Ranch Fire District (Arizona), Fort Worth Fire Department, and Grupo Modelo (AB InBev, which purchased 20,000 user licenses for a Zacatecas impaired-driving campaign). Distribution combines direct enterprise sales, self-serve app store downloads, channel partnerships with AlcoPro and Oracle, and an OEM-style integration with Neopharma Technologies.

Revenue is not publicly disclosed; the company is funded by an original NIH SBIR grant and operates with a disclosed headcount of 1-10 employees despite a leadership bench that includes a CEO with two prior IPOs, a CTO with Netflix and ADP experience, a board chaired by the Dean of the Merrick School of Business, and advisory members from BHP, Alcoa, the US Navy, NFPA, and the employee-screening industry. The platform is supported by 16+ peer-reviewed scientific studies and a 2025 Zurich Insurance Innovation Championship finalist recognition.

Name

Impairment Science

Legal name

Impairment Science, Inc.

Website

https://impairmentscience.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Impairment Science develops DRUID, a neuroscience-based mobile app and enterprise platform that uses machine learning to detect cognitive and motor impairment from any cause. It serves safety-critical industries, emergency services, cannabis operators, research institutions, and consumers.

Ownership category

akta.pro rank

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D

Revenue model

1. DRUID App Consumer Subscriptions: Mobile app sold directly to consumers via Apple App Store and Google Play. Free 14-day trial period, then $1.99/month or $14.99/year subscription. Allows unlimited testing per user.
2. DRUID Enterprise Platform Licensing: Cloud-based management portal and database for organizations. Pricing based on number of users, frequency of usage, and subscription duration. Provides real-time monitoring, analysis, automated alerts, scheduling, and data downloading.
3. Enterprise User Licensing: Volume-based licensing model where pricing is based on number of Enterprise users rather than per-test, enabling unlimited testing for organizations at predictable subscription costs.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

Core offering

Impairment Science develops and sells the DRUID platform, a mobile application and cloud-based enterprise portal that uses neuroscience-informed game-like tasks and proprietary machine learning algorithms to measure cognitive and motor impairment from any cause (drugs, alcohol, fatigue, illness, injury, stress). The DRUID App delivers a 1-minute Rapid Test or 3-minute Benchmark Test on standard smartphones, producing a 25-75 impairment score. DRUID Enterprise provides real-time monitoring, automated alerts, scheduling, and API integration with EHSQ/OHS platforms for organizational fit-for-duty programs.

Product overview

Impairment Science offers a platform-plus-modules product architecture centered on the DRUID cognitive and motor impairment testing ecosystem. The core product is the DRUID mobile app (available as 1-minute Rapid Test or 3-minute Benchmark Test), which pairs with DRUID Enterprise—the cloud-based management portal providing real-time score monitoring, analysis, and API integration with EHSQ/OHS platforms. The platform extends through DRUID True (patent-pending AI/ML anti-cheat technology for unsupervised testing) and the DRUID + NEOVAULT integration (combining Neopharma's digital drug testing with DRUID impairment assessment for a unified Fit-for-Duty solution). The entire platform is backed by 16+ peer-reviewed scientific studies validating accuracy.

Differentiator

Problem solved

Functional benefit

Brands

• DRUID App: Mobile app for cognitive and motor impairment testing using neuroscience-based assessment
• DRUID Enterprise
• DRUID True
• Rapid DRUID

Products and services

• DRUID App Mobile application that assesses cognitive and motor impairment through neuroscience-based game-like tasks measuring reaction time, hand-eye coordination, decision-making, time estimation, balance, and divided attention. Available with a 1-minute Rapid Test and a 3-minute Benchmark Test. Distributed via Apple App Store and Google Play with a 14-day free trial, $1.99/month or $14.99/year subscription. Used by individual consumers, athletes, and as the front-end for enterprise deployments.
• DRUID Enterprise Cloud-based management portal and database providing real-time monitoring and analysis of employees' or other participants' DRUID scores. Includes administrative functions, automated alerts, scheduling, and data downloading with API connections to EHSQ and OHS platforms. Sold to safety-critical organizations on per-user subscription licensing with unlimited testing. Used by mining companies, fire departments, construction firms, cannabis dispensaries, and other enterprises for pre-shift, post-accident, reasonable suspicion, return-to-duty, and random testing programs.

Quantifiable outcome

• F1 accuracy scores above 0.85 in distinguishing alcohol vs cannabis impairment in supervised testing
• +4 more outcomes

Named customers9 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

Six partnerships are on record, tiered minor and core.

• FluidLogicminorStrategic or Co-development Partner · 1 November 2025Partnership for Baja 1000 study where drivers use FluidLogic hydration systems and take DRUID tests before and after races to measure cognitive state and study hydration effects on performance.
• Johns Hopkins University (Cannabis Science Laboratory)coreStrategic or Co-development Partner · 1 October 2025Johns Hopkins National Cannabis Study using DRUID for objective cognitive performance measurement across 10,000 participants. DRUID is licensed to Johns Hopkins for research purposes. Study aims to understand health effects of medicinal cannabis.
• Zurich Insurance GroupminorGTM or Marketing Partner · 1 September 2025Selected as finalist in 2025 Zurich Innovation Championship, recognizing DRUID as leading impairment detection technology. Zurich's insurance innovation program provides industry validation and networking opportunities.
• Oracle (Oracle Partner Network)minorGTM or Marketing Partner · 1 March 2025Oracle Partner Network membership with presentation at Oracle Innovation Lab Worker Safety Summit in Chicago. Opportunity to showcase DRUID to Oracle clients and partners in construction and engineering industries.
• Neopharma TechnologiescoreTechnology or Integration · 1 February 2025February 2025 partnership announcement for integration of NEOVAULT digital drug test reporting with AI-powered cognitive impairment assessment tools. Full integration completed January 2026, creating unified Fit-for-Duty platform for digital drug, alcohol, and impairment assessment in one seamless workflow with API connections to leading EHSQ and OHS platforms.
• AlcoProcoreChannel Partner/ Reseller/ Distributor · 1 May 2024Strategic partnership announced May 2024 for AlcoPro to offer DRUID impairment technology to their customers. AlcoPro is a supplier of premium drug and alcohol testing products and training solutions serving employers.

Scale indicators9 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Sonde Health: Vocal and cognitive biomarker platform that detects health and cognitive conditions (including depression and mental wellness) using smartphone audio. Directly comparable to DRUID because it also translates passive or short active smartphone measurements into validated biomarkers for cognitive/mental state, and it is led by a board director of Impairment Science (James Harper).
• Soberlink: Provides remote alcohol monitoring with connected breathalyzer devices for workplace, legal, and clinical use cases. Directly comparable to DRUID Enterprise because it monetizes impairment data from safety-sensitive workforces via subscriptions and cloud dashboards, although it focuses on alcohol rather than broader cognitive impairment.
• BACtrack: Consumer and professional breathalyzer brand selling mobile-connected impairment detection devices at retail and to enterprise. Comparable to the consumer DRUID subscription in that it directly markets impairment self-testing to individuals via app stores and retail channels.
• Cambridge Cognition: Digital cognitive assessment platform (e.g., CANTAB) used in clinical trials and healthcare research. Directly comparable to DRUID because it sells validated computerized tests that measure cognitive performance, and it partners with pharmaceutical and academic researchers — overlapping with DRUID's neuroscience-derived battery.

Emerging players

• Linus Health: Digital cognitive assessment tools (e.g., DCTclock) for early detection of Alzheimer's and other neurodegenerative conditions. Comparable to DRUID in measuring cognitive function via short tablet- or app-based tasks, though focused on clinical brain-health workflows rather than workplace safety.
• Kintsugi: Voice-based biomarker startup using short audio clips to detect depression and other mental health conditions via smartphone. Comparable as an early-stage company applying ML to short, smartphone-delivered signals to infer cognitive/mental state, sharing a similar technical thesis and target enterprise buyer base as DRUID.

Others

• Neopharma Technologies (NEOVAULT): Digital drug-test reporting platform whose NEOVAULT product has been fully integrated with DRUID as of January 2026 to create a unified Fit-for-Duty platform. Listed as a core partner, making Neopharma the most adjacent solution for the same enterprise drug/impairment testing buyer.
• AlcoPro: Channel partner since May 2024 that distributes DRUID to its employer customers, while also selling competing drug and alcohol testing products. Comparable as a workplace drug/alcohol testing distributor addressing the same buyer with overlapping product categories.

Broad incumbents

• Quest Diagnostics: The dominant U.S. workplace drug testing laboratory, operating SAMHSA-certified panels and employer procurement programs. Relevant as the established incumbent whose customers DRUID must integrate with or displace in workplace safety testing.
• Laboratory Corporation of America (LabCorp): Major national clinical and workplace drug testing laboratory serving employer drug-free workplace programs. Comparable as an incumbent that DRUID would need to be paired with or displace to scale enterprise sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/impairmentsci
• YouTubeyoutube.com/@ImpairmentScience/featured
• LinkedInlinkedin.com/company/37896529

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Impairment Science